Emergent BioSolutions (EBS) Cash from Investing Activities (2010 - 2026)
Emergent BioSolutions (EBS) recorded Cash from Investing Activities of -$52.3 million in Q2 2026, compared with $17.2 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
On a TTM basis, Emergent BioSolutions' Cash from Investing Activities came in at -$62 million as of Jun 30, 2026; for FY2025, it was $69.4 million, down 44.6% from FY2024.
- Across earlier years, Cash from Investing Activities came in at $125.2 million in FY2024 (-41.0%), $212.3 million in FY2023, -$381.3 million in FY2022 and -$224.1 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Cash from Investing Activities since Q3 2022.
- Per Business Quant, the preceding three quarters came in at -$2.4 million (Q1 2026), -$3.9 million (Q4 2025) and -$3.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,127.89 Bn | 1,096.47 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 635.11 Bn | 554.97 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 504.69 Bn | 477.80 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 358.24 Bn | 312.62 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 290.13 Bn | 254.12 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 237.87 Bn | 193.27 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 194.91 Bn | 169.11 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Emergent BioSolutions | 320.18 Mn | -430.72 Mn | 137.20 Mn | -52.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -52.30 Mn |
| Mar 31, 2026 | -2.40 Mn |
| Dec 31, 2025 | -3.90 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Jun 30, 2025 | 17.20 Mn |
| Mar 31, 2025 | 59.50 Mn |
| Dec 31, 2024 | 28.60 Mn |
| Sep 30, 2024 | 112.00 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Mar 31, 2024 | -10.80 Mn |
| Dec 31, 2023 | -11.40 Mn |
| Sep 30, 2023 | -18.90 Mn |
| Jun 30, 2023 | 257.70 Mn |
| Mar 31, 2023 | -15.10 Mn |
| Dec 31, 2022 | -45.40 Mn |
| Sep 30, 2022 | -271.60 Mn |
| Jun 30, 2022 | -32.10 Mn |
| Mar 31, 2022 | -32.20 Mn |
| Dec 31, 2021 | -45.80 Mn |
| Sep 30, 2021 | -55.20 Mn |
API Access
Emergent BioSolutions Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();